203 related articles for article (PubMed ID: 30724915)
1. First-time oral administration of resveratrol-loaded layer-by-layer nanoparticles to rats - a pharmacokinetics study.
Santos AC; Veiga FJ; Sequeira JAD; Fortuna A; Falcão A; Pereira I; Pattekari P; Fontes-Ribeiro C; Ribeiro AJ
Analyst; 2019 Mar; 144(6):2062-2079. PubMed ID: 30724915
[TBL] [Abstract][Full Text] [Related]
2. Sonication-assisted Layer-by-Layer self-assembly nanoparticles for resveratrol delivery.
Santos AC; Sequeira JAD; Pereira I; Cabral C; Collado Gonzallez M; Fontes-Ribeiro C; Ribeiro AJ; Lvov YM; Veiga FJ
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110022. PubMed ID: 31546400
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.
Santos AC; Pereira I; Magalhães M; Pereira-Silva M; Caldas M; Ferreira L; Figueiras A; Ribeiro AJ; Veiga F
AAPS J; 2019 Apr; 21(4):57. PubMed ID: 31016543
[TBL] [Abstract][Full Text] [Related]
4. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Singh G; Pai RS
J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
[TBL] [Abstract][Full Text] [Related]
5. Zein nanoparticles as low-cost, safe, and effective carriers to improve the oral bioavailability of resveratrol.
Nunes R; Baião A; Monteiro D; das Neves J; Sarmento B
Drug Deliv Transl Res; 2020 Jun; 10(3):826-837. PubMed ID: 32207071
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats.
Naserifar M; Hosseinzadeh H; Abnous K; Mohammadi M; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Dec; 262():118555. PubMed ID: 33035579
[TBL] [Abstract][Full Text] [Related]
7. An exosomal approach for oral delivery of resveratrol: Implications for inflammatory bowel disease treatment in rat model.
Esfahani SK; Dehghani S; Hosseinzadeh H; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2024 Jun; 346():122638. PubMed ID: 38614294
[TBL] [Abstract][Full Text] [Related]
8. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
El-Habashy SE; Allam AN; El-Kamel AH
Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
[TBL] [Abstract][Full Text] [Related]
9. Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability.
Spogli R; Bastianini M; Ragonese F; Iannitti RG; Monarca L; Bastioli F; Nakashidze I; Brecchia G; Menchetti L; Codini M; Arcuri C; Mancinelli L; Fioretti B
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563110
[TBL] [Abstract][Full Text] [Related]
10. Sonication-Assisted Layer-by-Layer Assembly for Low Solubility Drug Nanoformulation.
Santos AC; Pattekari P; Jesus S; Veiga F; Lvov Y; Ribeiro AJ
ACS Appl Mater Interfaces; 2015 Jun; 7(22):11972-83. PubMed ID: 25985366
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy.
Wan S; Zhang L; Quan Y; Wei K
R Soc Open Sci; 2018 Nov; 5(11):181457. PubMed ID: 30564426
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability.
Wu M; Zhong C; Deng Y; Zhang Q; Zhang X; Zhao X
Drug Deliv; 2020 Dec; 27(1):81-90. PubMed ID: 31858857
[TBL] [Abstract][Full Text] [Related]
13. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
14. Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles.
Peñalva R; Morales J; González-Navarro CJ; Larrañeta E; Quincoces G; Peñuelas I; Irache JM
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231546
[TBL] [Abstract][Full Text] [Related]
15. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ
Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951
[TBL] [Abstract][Full Text] [Related]
16. Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride.
Varshosaz J; Minaiyan M; Dayyani L
Eur J Pharm Sci; 2018 Jan; 112():195-206. PubMed ID: 29196024
[TBL] [Abstract][Full Text] [Related]
17. Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol.
Chimento A; De Amicis F; Sirianni R; Sinicropi MS; Puoci F; Casaburi I; Saturnino C; Pezzi V
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893846
[TBL] [Abstract][Full Text] [Related]
18. Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study.
Salem HF; Kharshoum RM; Abou-Taleb HA; Naguib DM
AAPS PharmSciTech; 2019 May; 20(5):181. PubMed ID: 31049748
[TBL] [Abstract][Full Text] [Related]
19. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel conjugated resveratrol polymeric nanoparticles in reduction of plasma degradation, hepatic metabolism and its augmentation of anticancer activity in vitro and in vivo.
Yee YJ; Benson HAE; Dass CR; Chen Y
Int J Pharm; 2022 Mar; 615():121499. PubMed ID: 35065206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
